glp-1 agonist mechanism A Closer Look at the Dermatological Profile of Agonists The Cardiovascular Biology of Glucagon-like
Description
According to statistics, approximately 9.4 million people worldwide had PD in 2020, and the incidence is rising with global aging, especially in high-income and some middle-income countries (6, 7)
They work by engaging the same receptors on target cells as glucagon does, triggering a cascade of different effects in our body including blood sugar regulation, insulin secretion and appetite control and potentially even immune modulation
Some common side effects include nausea, vomiting, diarrhea, and constipation, especially when starting or increasing the dose
Eur J Immunol
This dual mechanismslowed emptying combined with enhanced satiety signalscreates a powerful effect on eating behavior
